Microarray Analysis of Gene Expression in Metastatic Gastric Cancer Cells After Incubation with the Methylation Inhibitor 5-aza-2'-deoxycytidine

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2005 Jan 28

PMID 15672863

Citations 7

Authors

Jie Chen

Christoph Rocken

Ludger Klein-Hitpass

Tobias Gotze

Andreas Leodolter

Peter Malfertheiner

Matthias P A Ebert

Affiliations

Soon will be listed here.

Abstract

While the exact mechanisms involved in cancer metastasis are not fully clarified, the altered expression of many different genes has been reported. Hypermethylation of the promoters of cancer-related genes is often associated with their inactivation during tumorigenesis and may also be involved in metastasis. Here we used cDNA microarrays to examine the different gene expression profiles of a primary gastric adenocarcinoma cell line RF1 and its derivative metastasis subline RF48. Compared with RF1, 49 genes were down-regulated and 8 genes were up-regulated in RF48. After treatment of RF48 cells with a DNA methylation inhibitor, 5-aza-2'-deoxycytidine, 101 genes were up-regulated and 1 gene was down-regulated in treated RF48 when compared with untreated RF48. Comparing gene expression patterns of untreated RF1, untreated RF48 and treated RF48 cells showed 5 genes expressed in RF1 but silenced in RF48, which were reactivated after 5-aza-2'-deoxycytidine treatment. Two of those 5 genes have CpG islands within their promoter regions, suggesting that those genes activated by 5-aza-2'-deoxycytidine may result from the direct inhibition of promoter methylation. In conclusion, using global gene expression analysis together with inhibition of DNA methylation, we demonstrate that hypermethylation of the promoters of certain cancer-related genes may play a role in cancer metastasis.

Citing Articles

How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression.

Wang Z, Snyder M, Kenison J, Yang K, Lara B, Lydell E Int J Mol Sci. 2021; 22(1).

PMID: 33396563 PMC: 7795223. DOI: 10.3390/ijms22010387.

Inhibitory effect of the low-toxic exogenous aryl hydrocarbon receptor modulator 3'3-diindolylmethane on gastric cancer in mice.

Su M, Qian C, Hu Y, Lu W, Huang R, Chen M Oncol Lett. 2018; 14(6):8100-8105.

PMID: 29344254 PMC: 5755176. DOI: 10.3892/ol.2017.7185.

Epigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequences.

Harizi H Mediators Inflamm. 2015; 2015:841097.

PMID: 25944989 PMC: 4402557. DOI: 10.1155/2015/841097.

Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.

Peng T, Chen J, Mao W, Song X, Chen M BMC Cell Biol. 2009; 10:27.

PMID: 19371443 PMC: 2680824. DOI: 10.1186/1471-2121-10-27.

Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer.

Peng T, Chen J, Mao W, Liu X, Tao Y, Chen L World J Gastroenterol. 2009; 15(14):1719-29.

PMID: 19360915 PMC: 2668777. DOI: 10.3748/wjg.15.1719.

References

Michalowsky L, Jones P . Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance. Mol Cell Biol. 1987; 7(9):3076-83. PMC: 367939. DOI: 10.1128/mcb.7.9.3076-3083.1987. View

Jones P, Taylor S . Cellular differentiation, cytidine analogs and DNA methylation. Cell. 1980; 20(1):85-93. DOI: 10.1016/0092-8674(80)90237-8. View

Guenzi E, Topolt K, Cornali E, Jorg A, Matzen K, Zietz C . The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 2001; 20(20):5568-77. PMC: 125279. DOI: 10.1093/emboj/20.20.5568. View

Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K . Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res. 2001; 61(3):889-95. View

Baugh L, Hill A, Brown E, Hunter C . Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res. 2001; 29(5):E29. PMC: 29742. DOI: 10.1093/nar/29.5.e29. View

Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw M, Pettersson S . A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci U S A. 2002; 99(15):9990-5. PMC: 126612. DOI: 10.1073/pnas.152706299. View

Boussioutas A, Li H, Liu J, Waring P, Lade S, Holloway A . Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 2003; 63(10):2569-77. View

Ozaki K, Nagata M, Suzuki M, Fujiwara T, Ueda K, Miyoshi Y . Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glycoproteins 1 and 2: significantly increased expression in cancers of various tissues. Cancer Res. 1998; 58(16):3499-503. View

Peifer M, Polakis P . Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. Science. 2000; 287(5458):1606-9. DOI: 10.1126/science.287.5458.1606. View

10.

Henry M, Cohen M, Campbell K . Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol. 2001; 32(8):791-5. DOI: 10.1053/hupa.2001.26468. View

11.

Tureci O, Chen Y, Sahin U, Gure A, Zwick C, Villena C . Expression of SSX genes in human tumors. Int J Cancer. 1998; 77(1):19-23. DOI: 10.1002/(sici)1097-0215(19980703)77:1<19::aid-ijc4>3.0.co;2-2. View

12.

Jones P, Laird P . Cancer epigenetics comes of age. Nat Genet. 1999; 21(2):163-7. DOI: 10.1038/5947. View

13.

Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G . Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol. 2003; 162(3):849-60. PMC: 1868099. DOI: 10.1016/S0002-9440(10)63881-3. View

14.

Koliopanos A, Kleeff J, Xiao Y, Safe S, Zimmermann A, Buchler M . Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene. 2002; 21(39):6059-70. DOI: 10.1038/sj.onc.1205633. View

15.

Esteller M, Corn P, Baylin S, Herman J . A gene hypermethylation profile of human cancer. Cancer Res. 2001; 61(8):3225-9. View

16.

Liang G, Gonzales F, Jones P, Orntoft T, Thykjaer T . Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine. Cancer Res. 2002; 62(4):961-6. View

17.

Baylin S, Herman J . DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000; 16(4):168-74. DOI: 10.1016/s0168-9525(99)01971-x. View

18.

Esteller M, Herman J . Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2001; 196(1):1-7. DOI: 10.1002/path.1024. View

19.

Bender C, Pao M, Jones P . Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res. 1998; 58(1):95-101. View

20.

Roukos D . Current status and future perspectives in gastric cancer management. Cancer Treat Rev. 2000; 26(4):243-55. DOI: 10.1053/ctrv.2000.0164. View